Keywords: hoechst, amaryl, approved, diabetes, its, first, markets

Hoechst's Amaryl Approved For Diabetes In Its First Markets

Article | 02 October 1995

Print This

Hoechst has announced that its new oral antidiabetic drug Amaryl (glimepiride) has now been approved in its first markets, the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in